We are live on
!
Find out more
OAM
Oxford Asset Management Portfolio holdings
AUM
$232M
1-Year Est. Return
31%
This Fund
S&P 500
This Quarter
Est. Return
+11.2%
1 Year Est. Return
+31%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$96.4M
AUM Growth
+$29.6M
(+44%)
Cap. Flow
+$25.4M
Cap. Flow
% of AUM
26.31%
Top 10 Holdings %
Top 10 Hldgs %
16.71%
Holding
393
New
214
Increased
20
Reduced
17
Closed
138
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$2.19M |
| 2 |
OSG
Overseas Shipholding Group Inc.
OSG
|
+$2.01M |
| 3 |
RCM
R1 RCM Inc. Common Stock
RCM
|
+$1.75M |
| 4 |
Cannae Holdings
CNNE
|
+$1.54M |
| 5 |
GeoPark
GPRK
|
+$1.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.06M |
| 2 |
ESMT
EngageSmart, Inc.
ESMT
|
+$1.03M |
| 3 |
TGH
Textainer Group Holdings limited
TGH
|
+$1.02M |
| 4 |
AYX
Alteryx Inc
AYX
|
+$1.01M |
| 5 |
Oracle
ORCL
|
+$964K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18.11% |
| 2 | Consumer Discretionary | 18.09% |
| 3 | Energy | 12.35% |
| 4 | Technology | 11.84% |
| 5 | Healthcare | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Taboola.com
TBLA
$1.11B
| $101K | 0.1% |
+22,679
| New | +$101K |
|
227
GrowGeneration
GRWG
$90.7M
| $95.7K | 0.1% |
+33,451
| New | +$77.2K |
|
228
Cytek Biosciences
CTKB
$546M
| $92.1K | 0.1% |
+13,726
| New | +$109K |
|
229
PLAYSTUDIOS Inc
MYPS
$90.1M
| $90.5K | 0.09% |
+32,552
| New | +$75.5K |
|
|
SEI
230
Solaris Energy Infrastructure
SEI
$3.82B
| $90K | 0.09% |
+10,377
| New | +$81.4K |
|
231
Alphabet (Google) Class A
GOOGL
$4.33T
| $87.4K | 0.09% |
+579
| New | +$82.8K |
|
|
BRY
232
DELISTED
Berry Corp
BRY
| $84.5K | 0.09% |
+10,500
| New | +$73.4K |
|
233
Fortuna Silver Mines
FSM
$3.07B
| $82K | 0.09% |
+21,985
| New | +$70.4K |
|
234
Pacific Biosciences
PACB
$370M
| $80.4K | 0.08% |
+21,451
| New | +$126K |
|
235
PetMed Express
PETS
$42.3M
| $76K | 0.08% |
+15,859
| New | +$92.2K |
|
236
Oil States International
OIS
$491M
| $75.1K | 0.08% |
+12,195
| New | +$72.8K |
|
|
MRSN
237
DELISTED
Mersana Therapeutics
MRSN
| $74.3K | 0.08% |
+663
| New | +$65.9K |
|
238
Vaalco Energy
EGY
$594M
| $74K | 0.08% |
+10,614
| New | +$49.7K |
|
239
Alector
ALEC
$199M
| $72.3K | 0.08% |
+12,002
| New | +$78.5K |
|
240
E.W. Scripps
SSP
$304M
| $68.4K | 0.07% |
+17,412
| New | +$104K |
|
241
Lucas GC Ltd
LGCL
$52.2M
| $65.8K | 0.07% |
+559
| New | +$73.3K |
|
242
Organogenesis Holdings
ORGO
$239M
| $64.3K | 0.07% |
+22,631
| New | +$76.9K |
|
|
GTHX
243
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $63.5K | 0.07% |
+14,703
| New | +$51.2K |
|
244
Humacyte
HUMA
$194M
| $63.4K | 0.07% |
+20,374
| New | +$68.5K |
|
245
Super Micro Computer
SMCI
$20.1B
| $56.6K | 0.06% |
+560
| New | +$41K |
|
246
Holley
HLLY
$384M
| $54.3K | 0.06% |
+12,169
| New | +$55.6K |
|
247
Compass
COMP
$9.66B
| $42.8K | 0.04% |
+11,887
| New | +$42K |
|
248
Akebia Therapeutics
AKBA
$252M
| $40.7K | 0.04% |
+22,262
| New | +$35.6K |
|
249
Upland Software
UPLD
$15.4M
| $39K | 0.04% |
1,263
+24
| +2% | +$870 |
|
|
WW
250
DELISTED
WW International
WW
| $34.8K | 0.04% |
+18,825
| New | +$74.9K |
|
Similar funds
KG
VOMP
TLA
RWS
SC
RWMG
TW
NTIC
Oxford Asset Management's Q1 2024 Portfolio in Review
As of Q1 2024, Oxford Asset Management held 393 positions worth $96.4M, up 44% from $66.8M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Oxford Asset Management deployed $25.4M of net new capital in Q1 2024, opening 214 new positions and adding to 20 existing holdings. Its largest new stake was Stellantis: 88,000 shares worth $2.49M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Micron Technology, an estimated $705K trimmed.
- Oxford Asset Management's largest Q1 2024 buy was Stellantis: 88,000 shares worth $2.49M.
- Oxford Asset Management added most to Daseke, Inc. Common Stock in Q1 2024, an estimated $624K increase.
- Oxford Asset Management's biggest Q1 2024 reduction was Micron Technology, cutting an estimated $705K.
- Oxford Asset Management fully exited Bristol-Myers Squibb in Q1 2024, selling an estimated $1.06M.
- Oxford Asset Management's ten largest holdings make up 17% of its $96.4M portfolio in Q1 2024.
- Oxford Asset Management opened 214 new positions and closed 138 in Q1 2024.
- Oxford Asset Management's portfolio value rose 44% quarter-over-quarter to $96.4M.
Based on Oxford Asset Management's 13F filing for Q1 2024, filed 15 May 2024.